世界の末期腎疾患(ESRD)治療薬市場インサイト及び予測(~2026年)

【英語タイトル】Global End-Stage Renal Disease (ESRD) Drugs Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV05699)・商品コード:QYR20NV05699
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは末期腎疾患(ESRD)治療薬の世界市場について調査・分析した資料です。種類別(コハク酸カルシウム、Mk-3866、パクリチニブ、サンギネート、テシドルマブ、その他)の市場規模、用途別(病院、クリニック、ICU、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別末期腎疾患(ESRD)治療薬の競争状況、市場シェア
・世界の末期腎疾患(ESRD)治療薬市場:種類別市場規模 2015年-2020年(コハク酸カルシウム、Mk-3866、パクリチニブ、サンギネート、テシドルマブ、その他)
・世界の末期腎疾患(ESRD)治療薬市場:種類別市場規模予測 2021年-2026年(コハク酸カルシウム、Mk-3866、パクリチニブ、サンギネート、テシドルマブ、その他)
・世界の末期腎疾患(ESRD)治療薬市場:用途別市場規模 2015年-2020年(病院、クリニック、ICU、その他)
・世界の末期腎疾患(ESRD)治療薬市場:用途別市場規模予測 2021年-2026年(病院、クリニック、ICU、その他)
・北米の末期腎疾患(ESRD)治療薬市場分析:米国、カナダ
・ヨーロッパの末期腎疾患(ESRD)治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの末期腎疾患(ESRD)治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の末期腎疾患(ESRD)治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの末期腎疾患(ESRD)治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):CTI BioPharma Corp、Merck & Co Inc、Novartis AG、Prolong Pharmaceuticals LLC、VESSL Therapeutics Ltd
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global End-Stage Renal Disease (ESRD) Drugs Market
The global End-Stage Renal Disease (ESRD) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global End-Stage Renal Disease (ESRD) Drugs Scope and Market Size
End-Stage Renal Disease (ESRD) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global End-Stage Renal Disease (ESRD) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the End-Stage Renal Disease (ESRD) Drugs market is segmented into
Calcium Succinate
Mk-3866
Pacritinib
Sanguinate
Tesidolumab
Others

Segment by Application, the End-Stage Renal Disease (ESRD) Drugs market is segmented into
Hospital
Clinic
ICU
Others

Regional and Country-level Analysis
The End-Stage Renal Disease (ESRD) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the End-Stage Renal Disease (ESRD) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and End-Stage Renal Disease (ESRD) Drugs Market Share Analysis
End-Stage Renal Disease (ESRD) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in End-Stage Renal Disease (ESRD) Drugs business, the date to enter into the End-Stage Renal Disease (ESRD) Drugs market, End-Stage Renal Disease (ESRD) Drugs product introduction, recent developments, etc.

The major vendors covered:
CTI BioPharma Corp
Merck & Co Inc
Novartis AG
Prolong Pharmaceuticals LLC
VESSL Therapeutics Ltd

【レポートの目次】

1 Study Coverage
1.1 End-Stage Renal Disease (ESRD) Drugs Product Introduction
1.2 Market Segments
1.3 Key End-Stage Renal Disease (ESRD) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Type
1.4.2 Calcium Succinate
1.4.3 Mk-3866
1.4.4 Pacritinib
1.4.5 Sanguinate
1.4.6 Tesidolumab
1.4.7 Others
1.5 Market by Application
1.5.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 ICU
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size, Estimates and Forecasts
2.1.1 Global End-Stage Renal Disease (ESRD) Drugs Revenue 2015-2026
2.1.2 Global End-Stage Renal Disease (ESRD) Drugs Sales 2015-2026
2.2 Global End-Stage Renal Disease (ESRD) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global End-Stage Renal Disease (ESRD) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global End-Stage Renal Disease (ESRD) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global End-Stage Renal Disease (ESRD) Drugs Competitor Landscape by Players
3.1 End-Stage Renal Disease (ESRD) Drugs Sales by Manufacturers
3.1.1 End-Stage Renal Disease (ESRD) Drugs Sales by Manufacturers (2015-2020)
3.1.2 End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturers
3.2.1 End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 End-Stage Renal Disease (ESRD) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global End-Stage Renal Disease (ESRD) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by End-Stage Renal Disease (ESRD) Drugs Revenue in 2019
3.2.5 Global End-Stage Renal Disease (ESRD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 End-Stage Renal Disease (ESRD) Drugs Price by Manufacturers
3.4 End-Stage Renal Disease (ESRD) Drugs Manufacturing Base Distribution, Product Types
3.4.1 End-Stage Renal Disease (ESRD) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into End-Stage Renal Disease (ESRD) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size by Type (2015-2020)
4.1.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2015-2020)
4.1.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2015-2020)
4.1.3 End-Stage Renal Disease (ESRD) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 End-Stage Renal Disease (ESRD) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global End-Stage Renal Disease (ESRD) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size by Application (2015-2020)
5.1.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2015-2020)
5.1.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2015-2020)
5.1.3 End-Stage Renal Disease (ESRD) Drugs Price by Application (2015-2020)
5.2 End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global End-Stage Renal Disease (ESRD) Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America End-Stage Renal Disease (ESRD) Drugs by Country
6.1.1 North America End-Stage Renal Disease (ESRD) Drugs Sales by Country
6.1.2 North America End-Stage Renal Disease (ESRD) Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Type
6.3 North America End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe End-Stage Renal Disease (ESRD) Drugs by Country
7.1.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country
7.1.2 Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Type
7.3 Europe End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs by Region
8.1.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region
8.1.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Type
8.3 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America End-Stage Renal Disease (ESRD) Drugs by Country
9.1.1 Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country
9.1.2 Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Type
9.3 Central & South America End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs by Country
10.1.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country
10.1.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Type
10.3 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 CTI BioPharma Corp
11.1.1 CTI BioPharma Corp Corporation Information
11.1.2 CTI BioPharma Corp Description and Business Overview
11.1.3 CTI BioPharma Corp Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Products Offered
11.1.5 CTI BioPharma Corp Related Developments
11.2 Merck & Co Inc
11.2.1 Merck & Co Inc Corporation Information
11.2.2 Merck & Co Inc Description and Business Overview
11.2.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Products Offered
11.2.5 Merck & Co Inc Related Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Description and Business Overview
11.3.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis AG End-Stage Renal Disease (ESRD) Drugs Products Offered
11.3.5 Novartis AG Related Developments
11.4 Prolong Pharmaceuticals LLC
11.4.1 Prolong Pharmaceuticals LLC Corporation Information
11.4.2 Prolong Pharmaceuticals LLC Description and Business Overview
11.4.3 Prolong Pharmaceuticals LLC Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Products Offered
11.4.5 Prolong Pharmaceuticals LLC Related Developments
11.5 VESSL Therapeutics Ltd
11.5.1 VESSL Therapeutics Ltd Corporation Information
11.5.2 VESSL Therapeutics Ltd Description and Business Overview
11.5.3 VESSL Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Products Offered
11.5.5 VESSL Therapeutics Ltd Related Developments
11.1 CTI BioPharma Corp
11.1.1 CTI BioPharma Corp Corporation Information
11.1.2 CTI BioPharma Corp Description and Business Overview
11.1.3 CTI BioPharma Corp Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Products Offered
11.1.5 CTI BioPharma Corp Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 End-Stage Renal Disease (ESRD) Drugs Market Estimates and Projections by Region
12.1.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Regions 2021-2026
12.2 North America End-Stage Renal Disease (ESRD) Drugs Market Size Forecast (2021-2026)
12.2.1 North America: End-Stage Renal Disease (ESRD) Drugs Sales Forecast (2021-2026)
12.2.2 North America: End-Stage Renal Disease (ESRD) Drugs Revenue Forecast (2021-2026)
12.2.3 North America: End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe End-Stage Renal Disease (ESRD) Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: End-Stage Renal Disease (ESRD) Drugs Sales Forecast (2021-2026)
12.3.2 Europe: End-Stage Renal Disease (ESRD) Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: End-Stage Renal Disease (ESRD) Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: End-Stage Renal Disease (ESRD) Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America End-Stage Renal Disease (ESRD) Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: End-Stage Renal Disease (ESRD) Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: End-Stage Renal Disease (ESRD) Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: End-Stage Renal Disease (ESRD) Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: End-Stage Renal Disease (ESRD) Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: End-Stage Renal Disease (ESRD) Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key End-Stage Renal Disease (ESRD) Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 End-Stage Renal Disease (ESRD) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. End-Stage Renal Disease (ESRD) Drugs Market Segments
Table 2. Ranking of Global Top End-Stage Renal Disease (ESRD) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Calcium Succinate
Table 5. Major Manufacturers of Mk-3866
Table 6. Major Manufacturers of Pacritinib
Table 7. Major Manufacturers of Sanguinate
Table 8. Major Manufacturers of Tesidolumab
Table 9. Major Manufacturers of Others
Table 10. Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global End-Stage Renal Disease (ESRD) Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global End-Stage Renal Disease (ESRD) Drugs Sales by Regions 2015-2020 (K Pcs)
Table 13. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global End-Stage Renal Disease (ESRD) Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global End-Stage Renal Disease (ESRD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global End-Stage Renal Disease (ESRD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in End-Stage Renal Disease (ESRD) Drugs as of 2019)
Table 19. End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. End-Stage Renal Disease (ESRD) Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers End-Stage Renal Disease (ESRD) Drugs Price (2015-2020) (USD/Pcs)
Table 22. End-Stage Renal Disease (ESRD) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Type
Table 24. Date of International Manufacturers Enter into End-Stage Renal Disease (ESRD) Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2015-2020) (K Pcs)
Table 27. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Type (2015-2020)
Table 28. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Type (2015-2020)
Table 30. End-Stage Renal Disease (ESRD) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2015-2020) (K Pcs)
Table 32. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Application (2015-2020)
Table 33. North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2015-2020) (K Pcs)
Table 34. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2015-2020)
Table 35. North America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 36. North America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country (2015-2020)
Table 37. North America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2015-2020) (K Pcs)
Table 38. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2015-2020)
Table 39. North America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2015-2020) (K Pcs)
Table 40. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2015-2020)
Table 41. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2015-2020) (K Pcs)
Table 42. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2015-2020)
Table 43. Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country (2015-2020)
Table 45. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Type (2015-2020) (K Pcs)
Table 46. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2015-2020)
Table 47. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Application (2015-2020) (K Pcs)
Table 48. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2015-2020)
Table 57. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country (2015-2020)
Table 61. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2015-2020)
Table 63. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2015-2020)
Table 73. CTI BioPharma Corp Corporation Information
Table 74. CTI BioPharma Corp Description and Major Businesses
Table 75. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. CTI BioPharma Corp Product
Table 77. CTI BioPharma Corp Recent Development
Table 78. Merck & Co Inc Corporation Information
Table 79. Merck & Co Inc Description and Major Businesses
Table 80. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Merck & Co Inc Product
Table 82. Merck & Co Inc Recent Development
Table 83. Novartis AG Corporation Information
Table 84. Novartis AG Description and Major Businesses
Table 85. Novartis AG End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Novartis AG Product
Table 87. Novartis AG Recent Development
Table 88. Prolong Pharmaceuticals LLC Corporation Information
Table 89. Prolong Pharmaceuticals LLC Description and Major Businesses
Table 90. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Prolong Pharmaceuticals LLC Product
Table 92. Prolong Pharmaceuticals LLC Recent Development
Table 93. VESSL Therapeutics Ltd Corporation Information
Table 94. VESSL Therapeutics Ltd Description and Major Businesses
Table 95. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. VESSL Therapeutics Ltd Product
Table 97. VESSL Therapeutics Ltd Recent Development
Table 98. Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 99. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 100. Global End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 101. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 102. North America: End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. North America: End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Europe: End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Europe: End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Asia Pacific: End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 107. Asia Pacific: End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 108. Latin America: End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Latin America: End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Middle East and Africa: End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. Middle East and Africa: End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 113. Key Challenges
Table 114. Market Risks
Table 115. Main Points Interviewed from Key End-Stage Renal Disease (ESRD) Drugs Players
Table 116. End-Stage Renal Disease (ESRD) Drugs Customers List
Table 117. End-Stage Renal Disease (ESRD) Drugs Distributors List
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. End-Stage Renal Disease (ESRD) Drugs Product Picture
Figure 2. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Calcium Succinate Product Picture
Figure 4. Mk-3866 Product Picture
Figure 5. Pacritinib Product Picture
Figure 6. Sanguinate Product Picture
Figure 7. Tesidolumab Product Picture
Figure 8. Others Product Picture
Figure 9. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. ICU
Figure 13. Others
Figure 14. End-Stage Renal Disease (ESRD) Drugs Report Years Considered
Figure 15. Global End-Stage Renal Disease (ESRD) Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global End-Stage Renal Disease (ESRD) Drugs Sales 2015-2026 (K Pcs)
Figure 17. Global End-Stage Renal Disease (ESRD) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region in 2019
Figure 20. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region in 2019
Figure 22. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by End-Stage Renal Disease (ESRD) Drugs Revenue in 2019
Figure 24. End-Stage Renal Disease (ESRD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2015-2020)
Figure 26. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type in 2019
Figure 27. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2015-2020)
Figure 28. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type in 2019
Figure 29. Global End-Stage Renal Disease (ESRD) Drugs Market Share by Price Range (2015-2020)
Figure 30. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2015-2020)
Figure 31. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application in 2019
Figure 32. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2015-2020)
Figure 33. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application in 2019
Figure 34. North America End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country in 2019
Figure 37. North America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country in 2019
Figure 38. U.S. End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America End-Stage Renal Disease (ESRD) Drugs Market Share by Type in 2019
Figure 43. North America End-Stage Renal Disease (ESRD) Drugs Market Share by Application in 2019
Figure 44. Europe End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country in 2019
Figure 47. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country in 2019
Figure 48. Germany End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe End-Stage Renal Disease (ESRD) Drugs Market Share by Type in 2019
Figure 59. Europe End-Stage Renal Disease (ESRD) Drugs Market Share by Application in 2019
Figure 60. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region in 2019
Figure 63. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region in 2019
Figure 64. China End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Market Share by Type in 2019
Figure 87. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Market Share by Application in 2019
Figure 88. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country in 2019
Figure 91. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country in 2019
Figure 92. Mexico End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America End-Stage Renal Disease (ESRD) Drugs Market Share by Type in 2019
Figure 99. Latin America End-Stage Renal Disease (ESRD) Drugs Market Share by Application in 2019
Figure 100. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Country in 2019
Figure 103. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Country in 2019
Figure 104. Turkey End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Share by Type in 2019
Figure 111. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Share by Application in 2019
Figure 112. North America End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed


【掲載企業】

CTI BioPharma Corp、Merck & Co Inc、Novartis AG、Prolong Pharmaceuticals LLC、VESSL Therapeutics Ltd

★調査レポート[世界の末期腎疾患(ESRD)治療薬市場インサイト及び予測(~2026年)] (コード:QYR20NV05699)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の末期腎疾患(ESRD)治療薬市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆